Meanwhile, our finding would seem to hint that there was a fluctuating change in the blood fractalkine levels during cognitive impairment, with stages of a rapid rise in modest impairment, then an obvious drop in serious impairment. The gene discussed is CX3CL1; the disease is Cognitive impairment.